Post-attachment neutralization of HPV16 by antibodies derived from Gardasil-vaccinated women
Authors:
Open Access
- 20 November 2025
- journal article
- Published by Springer Nature in npj Vaccines
- Vol. 10 (1) , 239
Abstract
HPV vaccines exhibit high type-specific and antibody-mediated protection against anogenital infection, even after a single dose. Complete and long-term “sterilizing” immunity against incident infection appears to be established in most HPV vaccinees, suggesting that not only are persistent levels of virus-inhibiting antibodies routinely generated but that they are also exceptionally potent at preventing infection. The process of HPV infection is unusually protracted at several steps, including slow internalization after the virions bind to the cell surface. This observation prompted us to comprehensively evaluate the ability of neutralizing antibodies to prevent infection subsequent to HPV pseudovirion attachment to cells. Using sera and memory B cell-derived monoclonal antibodies from Gardasil-vaccinated women, we observed almost complete post-attachment neutralization of HPV16 pseudovirion infection of HaCaT cells three hours after attachment, even when vaccinees’ sera were diluted 250-fold, with a gradual loss of activity up to 18 h. Unexpectedly, three distinct mechanisms of post-attachment neutralization were discovered, capsid shedding from the cell surface, capsid retention on the cell surface, and rapid capsid degradation after internalization.Keywords
Funding Information
- National Institutes of Health
This publication has 50 references indexed in Scilit:
- Virus neutralisation by intracellular antibodiesSeminars in Cell & Developmental Biology, 2022
- Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either Cervarix® or Gardasil® vaccineVaccine, 2019
- Explanations for the high potency of HPV prophylactic vaccinesVaccine, 2018
- A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virusAntiviral Research, 2017
- A Single Human Papillomavirus Vaccine Dose Improves B Cell Memory in Previously Infected SubjectsEBioMedicine, 2016
- Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya VirusCell Host & Microbe, 2015
- Concepts of papillomavirus entry into host cellsCurrent Opinion in Virology, 2014
- In Vivo Mechanisms of Vaccine-Induced Protection against HPV InfectionCell Host & Microbe, 2010
- Neutralization of animal virus infectivity by antibodyArchives of Virology, 2007
- Analysis of the Infectious Entry Pathway of Human Papillomavirus Type 33 PseudovirionsVirology, 2002